SE409414B - Sett att framstella farmaceutiska preparat innehallande kopparmyxin d v s kuprikomplexet av 6-metoxi-1-fenazinol-5,10-dioxid - Google Patents

Sett att framstella farmaceutiska preparat innehallande kopparmyxin d v s kuprikomplexet av 6-metoxi-1-fenazinol-5,10-dioxid

Info

Publication number
SE409414B
SE409414B SE531372A SE531372A SE409414B SE 409414 B SE409414 B SE 409414B SE 531372 A SE531372 A SE 531372A SE 531372 A SE531372 A SE 531372A SE 409414 B SE409414 B SE 409414B
Authority
SE
Sweden
Prior art keywords
coupric
coppermyxin
phenazinol
methoxy
dioxide
Prior art date
Application number
SE531372A
Other languages
English (en)
Inventor
G P Maestrone
M Mitrovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE409414B publication Critical patent/SE409414B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE531372A 1971-04-23 1972-04-21 Sett att framstella farmaceutiska preparat innehallande kopparmyxin d v s kuprikomplexet av 6-metoxi-1-fenazinol-5,10-dioxid SE409414B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13928971A 1971-04-23 1971-04-23

Publications (1)

Publication Number Publication Date
SE409414B true SE409414B (sv) 1979-08-20

Family

ID=22485947

Family Applications (1)

Application Number Title Priority Date Filing Date
SE531372A SE409414B (sv) 1971-04-23 1972-04-21 Sett att framstella farmaceutiska preparat innehallande kopparmyxin d v s kuprikomplexet av 6-metoxi-1-fenazinol-5,10-dioxid

Country Status (9)

Country Link
JP (1) JPS558964B1 (sv)
BE (1) BE782444A (sv)
CA (1) CA974170A (sv)
DE (1) DE2216892C2 (sv)
DK (1) DK131707C (sv)
FR (1) FR2133894B1 (sv)
GB (1) GB1333906A (sv)
NL (1) NL175261C (sv)
SE (1) SE409414B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965253A (en) * 1987-10-14 1990-10-23 University Of Florida Viscoelastic material for ophthalmic surgery
AU2010315083B2 (en) * 2009-11-06 2015-10-08 Carefusion 2200, Inc. Copper salts of ion exchange materials for use in the treatment and prevention of infections
US11007143B2 (en) 2013-03-15 2021-05-18 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
US11000545B2 (en) 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US11083750B2 (en) 2013-03-15 2021-08-10 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US10398733B2 (en) 2013-03-15 2019-09-03 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
US11318089B2 (en) * 2013-03-15 2022-05-03 Cda Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
US11193184B2 (en) 2019-02-22 2021-12-07 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL32324A (en) * 1968-06-24 1972-01-27 Sparamedica Ag Phenazine derivatives and their preparation

Also Published As

Publication number Publication date
NL7205526A (sv) 1972-10-25
DK131707B (da) 1975-08-25
DK131707C (da) 1976-01-26
FR2133894A1 (sv) 1972-12-01
DE2216892A1 (de) 1972-11-09
CA974170A (en) 1975-09-09
GB1333906A (en) 1973-10-17
BE782444A (fr) 1972-10-23
NL175261B (nl) 1984-05-16
NL175261C (nl) 1984-10-16
JPS558964B1 (sv) 1980-03-07
DE2216892C2 (de) 1983-01-05
FR2133894B1 (sv) 1975-10-17

Similar Documents

Publication Publication Date Title
NO741084L (no) Fremgangsmåte til fremstilling av orale legemiddelpreparater.
SE382459B (sv) Forfarande for framstellning av xantonderivat.
NL150680B (nl) Werkwijze ter bereiding van farmaceutische preparaten.
NL7413085A (nl) Farmaceutisch en/of cosmetisch preparaat uitwendig gebruik.
NL170229B (nl) Farmaceutisch combinatiepreparaat.
NL174547C (nl) Werkwijze ter bereiding van benzoylpropionzuurderivaten, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
NL7410371A (nl) Farmaceutische of cosmetische preparaten.
IL42311A0 (en) Cyclic sulphur compounds,their preparation and pharmaceutical preparations containing them
NL168210B (nl) Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van cyclische carbon- zuurderivaten.
IL35542A (en) 3-(5-nitrofuryl)-pyrazolopyrimidinone derivatives,their production and pharmaceutical preparations containing them
SE409414B (sv) Sett att framstella farmaceutiska preparat innehallande kopparmyxin d v s kuprikomplexet av 6-metoxi-1-fenazinol-5,10-dioxid
SE410603B (sv) Forfarande for framstellning av d-2,6-dimetyl-8-cyano- eller 8-karboxamido-metylergolin
NL7508706A (nl) Werkwijze ter bereiding van pyrazofurinederivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten.
SE399557B (sv) Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat
SE406587B (sv) Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin
SE412235B (sv) Analogiforfarande for framstellning av n-(furyl-och tienylmetyl)-6,14-endoeteno-7 alfa-hydroxialkyltetrahydronororipaviner- och -tebainer
BE792079A (fr) Nouveaux composes insatures, leur preparation et leur application commemedicaments
NL7414059A (nl) Pigmentpreparaten, werkwijzen voor hun bereiding en hun toepassing.
SE7509123L (sv) 3-metylpyrazol-5-karboxylat, sett att framstella desamma och lekemedelpreparat innehallande desamma.
IL38467A0 (en) 6-aminopenicillanic acid derivatives,their manufacture and pharmaceutical compositions containing them
SE383521B (sv) Forfarande for framstellning av kardenolid-3-(2',3-dedesoxi-2,'3'-oxido-glykosider).
NO144488C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater
SE398644B (sv) Sett att framstella farmaceutiskt aktiva 2,10-diklor-12-metyl-(2h-dibenso(d g))1,3)-dioxocinderivat
FI49029C (sv) Förfarande för framställning av 15alfa,16alfa-metylenandrostenderivat
IL43284A0 (en) New derivatives of 3-amino-5-sulfamoyl-benzoic acid,their manufacture and pharmaceutical preparations containing the